What is Apyx Medical Corporation's market cap?

Apyx Medical Corporation (APYX) has a market capitalization of $163.8M and trades on NASDAQ.

What is Apyx Medical Corporation's revenue and profitability?

Apyx Medical Corporation generated $55.9M in trailing twelve-month revenue with a net loss of $9.1M, representing a net margin of -16.2%. Gross margin stands at 61.9%, with free cash flow of -$9.0M. These figures are based on the Q1 2026 filing.

Who are Apyx Medical Corporation's competitors?

Apyx Medical Corporation's key competitors include Solta Medical, InMode Ltd., Artivion, Inc., and others. These companies compete in similar markets and product categories.

Who does Apyx Medical Corporation partner with?

Apyx Medical Corporation's notable partners include Symmetry Surgical, Perceptive Credit Holdings IV, LP.

What subsidiaries does Apyx Medical Corporation have?

Apyx Medical Corporation's subsidiaries include Apyx Bulgaria EOOD, Apyx China Holding Corp..

Where is Apyx Medical Corporation headquartered?

Apyx Medical Corporation is headquartered in United States of America and employs approximately 252 people. It has been publicly traded since 1994.

Apyx Medical Corporation

APYX

Apyx Medical Corporation is a surgical aesthetics company specializing in the development and commercialization of innovative energy-based medical devices.

Market cap

$163.81M+128%

Revenue$55.9M+18.2%

Net income-$9.1M+54.9%

Free cash flow-$9.0M+31.6%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$12.5MBeat by $2.0M EPS-$0.05Beat by $0.06

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$13.2M

EPS estimate-$0.06

Financials

Q1 2026

Income statement

See full

Revenue$12.5M+32.4%

Net income-$2.1M+48.6%

Balance sheet

See full

Cash & equivalents$31.1M+0.4%

Total debt$39.5M+1.4%

Total equity$12.8M+22.1%

Total assets$63.0M+4.8%

Cash flow

See full

Operating cash flow-$572.0K+18.5%

CapEx$60.0K+9.1%

Free cash flow-$632.0K+16.5%

Valuation & ratios

Valuation

See full

Market cap$163.81M+128%

Enterprise value$172.13M+70.0%

P/S2.9×+1.0×

Profitability

See full

Net margin-16.2%-6.2pp

FCF margin-16.1%-4.8pp

Returns & leverage

See full

Return on equity-77.8%-22.4pp

Debt / equity3.1×-0.6×

Current ratio5.8×+0.3×

Segments

By segment

See full

Oem$1.8M+13.8%

Competitors

By market cap

Haemonetics$3.6B+1.2%

Bausch Health Companies$1.7B-34.3%

Artivion$1.3B-14.0%

PROCEPT BioRobotics Corporation$1.0B—

InMode$884.1M-0.2%

AngioDynamics$564.6M+52.4%

Apyx Medical Corporation$163.8M+79.1%

RenovoRx$43.5M-4.8%

By revenue growth

PROCEPT BioRobotics Corporation+29.3%

Apyx Medical Corporation+18.2%

Artivion+17.6%

AngioDynamics+9.5%

Bausch Health Companies+8.2%

Haemonetics-2.0%

By net margin

Haemonetics13.31%—

Artivion2.55%+8.0pp

Bausch Health Companies-1.88%-9.1pp

AngioDynamics-11.48%+0.1pp

Apyx Medical Corporation-16.24%+26.3pp

PROCEPT BioRobotics Corporation-31.82%+4.4pp

Profile

Apyx Medical Corporation is a surgical aesthetics company specializing in the development and commercialization of innovative energy-based medical devices. The company's core value proposition centers on its proprietary Helium Plasma Technology, which provides surgeons with precise, controlled heat for tissue contraction and body contouring. They serve the cosmetic surgery and hospital surgical markets through both direct sales and original equipment manufacturer (OEM) partnerships.

Competitive position

Apyx Medical is a leader in helium-based plasma technology for surgical aesthetics, holding a unique regulatory position with specific FDA indications for tissue contraction.

GeographiesUnited States, Bulgaria, China, European Union

Customer segmentsHealthcare Providers, Medical Device Companies

Business modelManufacturing, Direct-to-Professional, B2B, OEM

SuppliersHelium gas suppliers, Semiconductor manufacturers, Plastic component suppliers, Contract component manufacturers

CustomersPhysician practices, Outpatient surgical centers, Hospitals, International medical distributors, OEM partners

CountryUnited States of America

Listed1994

Employees252.0

CEOCharles D. Goodwin

SectorHealthcare

IndustryMedical - Devices

Websiteapyxmedical.com

FilingsSEC EDGAR

Ask your AI about Apyx Medical Corporation.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Apyx Medical Corporation's market cap?: Apyx Medical Corporation (APYX) has a market capitalization of $163.8M and trades on NASDAQ.
What is Apyx Medical Corporation's revenue and profitability?: Apyx Medical Corporation generated $55.9M in trailing twelve-month revenue with a net loss of $9.1M, representing a net margin of -16.2%. Gross margin stands at 61.9%, with free cash flow of -$9.0M. These figures are based on the Q1 2026 filing.
Who are Apyx Medical Corporation's competitors?: Apyx Medical Corporation's key competitors include Solta Medical, InMode Ltd., Artivion, Inc., and others. These companies compete in similar markets and product categories.
Who does Apyx Medical Corporation partner with?: Apyx Medical Corporation's notable partners include Symmetry Surgical, Perceptive Credit Holdings IV, LP.
What subsidiaries does Apyx Medical Corporation have?: Apyx Medical Corporation's subsidiaries include Apyx Bulgaria EOOD, Apyx China Holding Corp..
Where is Apyx Medical Corporation headquartered?: Apyx Medical Corporation is headquartered in United States of America and employs approximately 252 people. It has been publicly traded since 1994.